Impact of Botulinum Toxin Injections on Quality of Life of Patients with Long-Standing Peripheral Facial Palsy
Jérémy Amar,
Frédéric Tankere,
Diane Picard
et al.
Abstract:(1) Background: Sequels of facial palsy lead to major psychosocial repercussions, disrupting patients’ quality of life (QoL). Botulinum toxin (BoNT) injections can permit us to treat long-standing facial palsy, improving facial symmetry and functional signs including synkinesis and contractures. (2) Methods: The main aim of this study was to assess the evolution of the QoL for patients with long-standing facial palsy before, at 1 month, and at 4 months after BoNT injections by using three questionnaires (HFS-3… Show more
“…In our experience, analysing retrospectively the successive injection records of 88 patients with sequelae of peripheral facial paralysis of any etiology, managed in our center, we studied the number of injections and doses per site [ 11 ]. The mean number of injection sites on the paralyzed side was 17.3 ± 5.1, and the mean number of units injected was 44.6 ± 13.…”
Section: Toxin Botulinum In Patients With Sequelae Of Peripheral Faci...mentioning
confidence: 99%
“…It can also improve mobility on the paralyzed side [ 10 ]. In this way, botulinum injections increase the quality of life for patients [ 11 ]. The side effects are minor and reversible over time.…”
Long-standing facial palsy sequelae cause functional, aesthetic, and psychological problems in patients. Botulinum toxin is an effective way to manage them, but no standardized recommendations exist. Through this non-systematic review, we aimed to guide any practitioner willing to master the ins and outs of this activity. We reviewed the existing literature and completed, with our experience as a reference center, different strategies of botulinum toxin injections used in facial palsy patients, including history, physiopathology, facial analysis, dosages, injection sites, and techniques, as well as time intervals between injections. The reader will find all the theorical information needed to best guide injections according to the patient’s complaint, which is the most important information to consider.
“…In our experience, analysing retrospectively the successive injection records of 88 patients with sequelae of peripheral facial paralysis of any etiology, managed in our center, we studied the number of injections and doses per site [ 11 ]. The mean number of injection sites on the paralyzed side was 17.3 ± 5.1, and the mean number of units injected was 44.6 ± 13.…”
Section: Toxin Botulinum In Patients With Sequelae Of Peripheral Faci...mentioning
confidence: 99%
“…It can also improve mobility on the paralyzed side [ 10 ]. In this way, botulinum injections increase the quality of life for patients [ 11 ]. The side effects are minor and reversible over time.…”
Long-standing facial palsy sequelae cause functional, aesthetic, and psychological problems in patients. Botulinum toxin is an effective way to manage them, but no standardized recommendations exist. Through this non-systematic review, we aimed to guide any practitioner willing to master the ins and outs of this activity. We reviewed the existing literature and completed, with our experience as a reference center, different strategies of botulinum toxin injections used in facial palsy patients, including history, physiopathology, facial analysis, dosages, injection sites, and techniques, as well as time intervals between injections. The reader will find all the theorical information needed to best guide injections according to the patient’s complaint, which is the most important information to consider.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.